Los Angeles Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Sell |
135,965
-26,165
| -16% | -$57.6K | ﹤0.01% | 1047 |
|
|
2025
Q1 | $188K | Buy |
162,130
+63,291
| +64% | +$73.4K | ﹤0.01% | 1027 |
|
|
2024
Q4 | $126K | Sell |
98,839
-18,800
| -16% | -$23.9K | ﹤0.01% | 1082 |
|
|
2024
Q3 | $401K | Sell |
117,639
-13,310
| -10% | -$45.4K | ﹤0.01% | 924 |
|
|
2024
Q2 | $612K | Sell |
130,949
-16,934
| -11% | -$79.1K | ﹤0.01% | 802 |
|
|
2024
Q1 | $1.1M | Buy |
+147,883
| New | +$1.1M | ﹤0.01% | 667 |
|
|
2022
Q4 | – | Sell |
-36,453
| Closed | -$446K | – | 1210 |
|
|
2022
Q3 | $446K | Buy |
36,453
+387
| +1% | +$4.74K | ﹤0.01% | 954 |
|
|
2022
Q2 | $427K | Buy |
36,066
+4,177
| +13% | +$49.5K | ﹤0.01% | 1022 |
|
|
2022
Q1 | $607K | Buy |
31,889
+15,745
| +98% | +$300K | ﹤0.01% | 957 |
|
|
2021
Q4 | $429K | Sell |
16,144
-167
| -1% | -$4.44K | ﹤0.01% | 1080 |
|
|
2021
Q3 | $670K | Hold |
16,311
| – | – | ﹤0.01% | 923 |
|
|
2021
Q2 | $924K | Sell |
16,311
-3,940
| -19% | -$223K | ﹤0.01% | 898 |
|
|
2021
Q1 | $851K | Sell |
20,251
-18,601
| -48% | -$782K | ﹤0.01% | 966 |
|
|
2020
Q4 | $2.72M | Sell |
38,852
-6,790
| -15% | -$476K | 0.01% | 566 |
|
|
2020
Q3 | $1.28M | Sell |
45,642
-13,890
| -23% | -$390K | 0.01% | 728 |
|
|
2020
Q2 | $1.76M | Sell |
59,532
-3,070
| -5% | -$90.8K | 0.01% | 641 |
|
|
2020
Q1 | $1.24M | Buy |
62,602
+4,105
| +7% | +$81.4K | 0.01% | 656 |
|
|
2019
Q4 | $1.73M | Buy |
+58,497
| New | +$1.73M | 0.01% | 682 |
|
|
2019
Q3 | – | Sell |
-12,705
| Closed | -$314K | – | 1285 |
|
|
2019
Q2 | $314K | Sell |
12,705
-5,220
| -29% | -$129K | ﹤0.01% | 1175 |
|
|
2019
Q1 | $438K | Buy |
+17,925
| New | +$438K | ﹤0.01% | 1122 |
|